Feasibility and accuracy of mobile QT interval monitoring strategies in bedaquiline‐enhanced prophylactic leprosy treatment

Some anti‐mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life‐threatening ventricular arrhythmia. However, the highest leprosy and tuberculosis burden occurs in settings where electrocardiographic monitoring is challenging. The feasibility and accuracy of alt...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and translational science Vol. 17; no. 8; pp. e13861 - n/a
Main Authors: Bergeman, Auke T., Nourdine, Said, Piubello, Alberto, Salim, Zahara, Braet, Sofie M., Baco, Abdallah, Grillone, Silahi H., Snijders, Rian, Hoof, Carolien, Tsoumanis, Achilleas, Loen, Harry, Assoumani, Younoussa, Mzembaba, Aboubacar, Ortuño‐Gutiérrez, Nimer, Hasker, Epco, Werf, Christian, Jong, Bouke C.
Format: Journal Article
Language:English
Published: United States John Wiley & Sons, Inc 01.08.2024
John Wiley and Sons Inc
Wiley
Subjects:
ISSN:1752-8054, 1752-8062, 1752-8062
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Some anti‐mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life‐threatening ventricular arrhythmia. However, the highest leprosy and tuberculosis burden occurs in settings where electrocardiographic monitoring is challenging. The feasibility and accuracy of alternative strategies, such as the use of automated measurements or a mobile electrocardiogram (mECG) device, have not been evaluated in this context. As part of the phase II randomized controlled BE‐PEOPLE trial evaluating the safety of bedaquiline‐enhanced post‐exposure prophylaxis (bedaquiline and rifampicin, BE‐PEP, versus rifampicin, SDR‐PEP) for leprosy, all participants had corrected QT intervals (QTc) measured at baseline and on the day after receiving post‐exposure prophylaxis. The accuracy of mECG measurements as well as automated 12L‐ECG measurements was evaluated. In total, 635 mECGs from 323 participants were recorded, of which 616 (97%) were of sufficient quality for QTc measurement. Mean manually read QTc on 12L‐ECG and mECG were 394 ± 19 and 385 ± 18 ms, respectively (p < 0.001), with a strong correlation (r = 0.793). The mean absolute QTc difference between both modalities was 11 ± 10 ms. Mean manual and automated 12L‐ECG QTc were 394 ± 19 and 409 ± 19 ms, respectively (n = 636; p < 0.001), corresponding to moderate agreement (r = 0.655). The use of a mECG device for QT interval monitoring was feasible and yielded a median absolute QTc error of 8 ms. Automated QTc measurements were less accurate, yielding longer QTc intervals.
AbstractList Some anti-mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life-threatening ventricular arrhythmia. However, the highest leprosy and tuberculosis burden occurs in settings where electrocardiographic monitoring is challenging. The feasibility and accuracy of alternative strategies, such as the use of automated measurements or a mobile electrocardiogram (mECG) device, have not been evaluated in this context. As part of the phase II randomized controlled BE-PEOPLE trial evaluating the safety of bedaquiline-enhanced post-exposure prophylaxis (bedaquiline and rifampicin, BE-PEP, versus rifampicin, SDR-PEP) for leprosy, all participants had corrected QT intervals (QTc) measured at baseline and on the day after receiving post-exposure prophylaxis. The accuracy of mECG measurements as well as automated 12L-ECG measurements was evaluated. In total, 635 mECGs from 323 participants were recorded, of which 616 (97%) were of sufficient quality for QTc measurement. Mean manually read QTc on 12L-ECG and mECG were 394 ± 19 and 385 ± 18 ms, respectively (p < 0.001), with a strong correlation (r = 0.793). The mean absolute QTc difference between both modalities was 11 ± 10 ms. Mean manual and automated 12L-ECG QTc were 394 ± 19 and 409 ± 19 ms, respectively (n = 636; p < 0.001), corresponding to moderate agreement (r = 0.655). The use of a mECG device for QT interval monitoring was feasible and yielded a median absolute QTc error of 8 ms. Automated QTc measurements were less accurate, yielding longer QTc intervals.Some anti-mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life-threatening ventricular arrhythmia. However, the highest leprosy and tuberculosis burden occurs in settings where electrocardiographic monitoring is challenging. The feasibility and accuracy of alternative strategies, such as the use of automated measurements or a mobile electrocardiogram (mECG) device, have not been evaluated in this context. As part of the phase II randomized controlled BE-PEOPLE trial evaluating the safety of bedaquiline-enhanced post-exposure prophylaxis (bedaquiline and rifampicin, BE-PEP, versus rifampicin, SDR-PEP) for leprosy, all participants had corrected QT intervals (QTc) measured at baseline and on the day after receiving post-exposure prophylaxis. The accuracy of mECG measurements as well as automated 12L-ECG measurements was evaluated. In total, 635 mECGs from 323 participants were recorded, of which 616 (97%) were of sufficient quality for QTc measurement. Mean manually read QTc on 12L-ECG and mECG were 394 ± 19 and 385 ± 18 ms, respectively (p < 0.001), with a strong correlation (r = 0.793). The mean absolute QTc difference between both modalities was 11 ± 10 ms. Mean manual and automated 12L-ECG QTc were 394 ± 19 and 409 ± 19 ms, respectively (n = 636; p < 0.001), corresponding to moderate agreement (r = 0.655). The use of a mECG device for QT interval monitoring was feasible and yielded a median absolute QTc error of 8 ms. Automated QTc measurements were less accurate, yielding longer QTc intervals.
Abstract Some anti‐mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life‐threatening ventricular arrhythmia. However, the highest leprosy and tuberculosis burden occurs in settings where electrocardiographic monitoring is challenging. The feasibility and accuracy of alternative strategies, such as the use of automated measurements or a mobile electrocardiogram (mECG) device, have not been evaluated in this context. As part of the phase II randomized controlled BE‐PEOPLE trial evaluating the safety of bedaquiline‐enhanced post‐exposure prophylaxis (bedaquiline and rifampicin, BE‐PEP, versus rifampicin, SDR‐PEP) for leprosy, all participants had corrected QT intervals (QTc) measured at baseline and on the day after receiving post‐exposure prophylaxis. The accuracy of mECG measurements as well as automated 12L‐ECG measurements was evaluated. In total, 635 mECGs from 323 participants were recorded, of which 616 (97%) were of sufficient quality for QTc measurement. Mean manually read QTc on 12L‐ECG and mECG were 394 ± 19 and 385 ± 18 ms, respectively (p < 0.001), with a strong correlation (r = 0.793). The mean absolute QTc difference between both modalities was 11 ± 10 ms. Mean manual and automated 12L‐ECG QTc were 394 ± 19 and 409 ± 19 ms, respectively (n = 636; p < 0.001), corresponding to moderate agreement (r = 0.655). The use of a mECG device for QT interval monitoring was feasible and yielded a median absolute QTc error of 8 ms. Automated QTc measurements were less accurate, yielding longer QTc intervals.
Some anti‐mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life‐threatening ventricular arrhythmia. However, the highest leprosy and tuberculosis burden occurs in settings where electrocardiographic monitoring is challenging. The feasibility and accuracy of alternative strategies, such as the use of automated measurements or a mobile electrocardiogram (mECG) device, have not been evaluated in this context. As part of the phase II randomized controlled BE‐PEOPLE trial evaluating the safety of bedaquiline‐enhanced post‐exposure prophylaxis (bedaquiline and rifampicin, BE‐PEP, versus rifampicin, SDR‐PEP) for leprosy, all participants had corrected QT intervals (QTc) measured at baseline and on the day after receiving post‐exposure prophylaxis. The accuracy of mECG measurements as well as automated 12L‐ECG measurements was evaluated. In total, 635 mECGs from 323 participants were recorded, of which 616 (97%) were of sufficient quality for QTc measurement. Mean manually read QTc on 12L‐ECG and mECG were 394 ± 19 and 385 ± 18 ms, respectively (p < 0.001), with a strong correlation (r = 0.793). The mean absolute QTc difference between both modalities was 11 ± 10 ms. Mean manual and automated 12L‐ECG QTc were 394 ± 19 and 409 ± 19 ms, respectively (n = 636; p < 0.001), corresponding to moderate agreement (r = 0.655). The use of a mECG device for QT interval monitoring was feasible and yielded a median absolute QTc error of 8 ms. Automated QTc measurements were less accurate, yielding longer QTc intervals.
Some anti‐mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life‐threatening ventricular arrhythmia. However, the highest leprosy and tuberculosis burden occurs in settings where electrocardiographic monitoring is challenging. The feasibility and accuracy of alternative strategies, such as the use of automated measurements or a mobile electrocardiogram (mECG) device, have not been evaluated in this context. As part of the phase II randomized controlled BE‐PEOPLE trial evaluating the safety of bedaquiline‐enhanced post‐exposure prophylaxis (bedaquiline and rifampicin, BE‐PEP, versus rifampicin, SDR‐PEP) for leprosy, all participants had corrected QT intervals (QTc) measured at baseline and on the day after receiving post‐exposure prophylaxis. The accuracy of mECG measurements as well as automated 12L‐ECG measurements was evaluated. In total, 635 mECGs from 323 participants were recorded, of which 616 (97%) were of sufficient quality for QTc measurement. Mean manually read QTc on 12L‐ECG and mECG were 394 ± 19 and 385 ± 18 ms, respectively ( p  < 0.001), with a strong correlation ( r  = 0.793). The mean absolute QTc difference between both modalities was 11 ± 10 ms. Mean manual and automated 12L‐ECG QTc were 394 ± 19 and 409 ± 19 ms, respectively ( n  = 636; p  < 0.001), corresponding to moderate agreement ( r  = 0.655). The use of a mECG device for QT interval monitoring was feasible and yielded a median absolute QTc error of 8 ms. Automated QTc measurements were less accurate, yielding longer QTc intervals.
Author Bergeman, Auke T.
Assoumani, Younoussa
Mzembaba, Aboubacar
Hasker, Epco
Tsoumanis, Achilleas
Ortuño‐Gutiérrez, Nimer
Loen, Harry
Snijders, Rian
Werf, Christian
Nourdine, Said
Hoof, Carolien
Piubello, Alberto
Braet, Sofie M.
Jong, Bouke C.
Salim, Zahara
Grillone, Silahi H.
Baco, Abdallah
AuthorAffiliation 1 Department of Cardiology, Heart Centre, Amsterdam UMC location AMC University of Amsterdam Amsterdam The Netherlands
2 National Tuberculosis and Leprosy Control Program Moroni Comoros
4 Institute of Tropical Medicine Antwerp Belgium
3 Damien Foundation Brussels Belgium
AuthorAffiliation_xml – name: 4 Institute of Tropical Medicine Antwerp Belgium
– name: 2 National Tuberculosis and Leprosy Control Program Moroni Comoros
– name: 1 Department of Cardiology, Heart Centre, Amsterdam UMC location AMC University of Amsterdam Amsterdam The Netherlands
– name: 3 Damien Foundation Brussels Belgium
Author_xml – sequence: 1
  givenname: Auke T.
  orcidid: 0000-0002-3881-9105
  surname: Bergeman
  fullname: Bergeman, Auke T.
  email: a.t.bergeman@amsterdamumc.nl
  organization: University of Amsterdam
– sequence: 2
  givenname: Said
  surname: Nourdine
  fullname: Nourdine, Said
  organization: National Tuberculosis and Leprosy Control Program
– sequence: 3
  givenname: Alberto
  surname: Piubello
  fullname: Piubello, Alberto
  organization: Damien Foundation
– sequence: 4
  givenname: Zahara
  surname: Salim
  fullname: Salim, Zahara
  organization: National Tuberculosis and Leprosy Control Program
– sequence: 5
  givenname: Sofie M.
  orcidid: 0000-0003-3291-8257
  surname: Braet
  fullname: Braet, Sofie M.
  organization: Institute of Tropical Medicine
– sequence: 6
  givenname: Abdallah
  surname: Baco
  fullname: Baco, Abdallah
  organization: National Tuberculosis and Leprosy Control Program
– sequence: 7
  givenname: Silahi H.
  surname: Grillone
  fullname: Grillone, Silahi H.
  organization: National Tuberculosis and Leprosy Control Program
– sequence: 8
  givenname: Rian
  surname: Snijders
  fullname: Snijders, Rian
  organization: Institute of Tropical Medicine
– sequence: 9
  givenname: Carolien
  surname: Hoof
  fullname: Hoof, Carolien
  organization: Institute of Tropical Medicine
– sequence: 10
  givenname: Achilleas
  surname: Tsoumanis
  fullname: Tsoumanis, Achilleas
  organization: Institute of Tropical Medicine
– sequence: 11
  givenname: Harry
  orcidid: 0009-0000-4448-0526
  surname: Loen
  fullname: Loen, Harry
  organization: Institute of Tropical Medicine
– sequence: 12
  givenname: Younoussa
  surname: Assoumani
  fullname: Assoumani, Younoussa
  organization: National Tuberculosis and Leprosy Control Program
– sequence: 13
  givenname: Aboubacar
  surname: Mzembaba
  fullname: Mzembaba, Aboubacar
  organization: National Tuberculosis and Leprosy Control Program
– sequence: 14
  givenname: Nimer
  surname: Ortuño‐Gutiérrez
  fullname: Ortuño‐Gutiérrez, Nimer
  organization: Damien Foundation
– sequence: 15
  givenname: Epco
  surname: Hasker
  fullname: Hasker, Epco
  organization: Institute of Tropical Medicine
– sequence: 16
  givenname: Christian
  orcidid: 0000-0001-8703-8527
  surname: Werf
  fullname: Werf, Christian
  organization: University of Amsterdam
– sequence: 17
  givenname: Bouke C.
  orcidid: 0000-0002-1017-4675
  surname: Jong
  fullname: Jong, Bouke C.
  organization: Institute of Tropical Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39075882$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1u1DAQgCNURH_gwAsgS1zgsK1_4sQ5IbSiUKkSQixna-KMd73K2ls7KcoBiUfgGXkSTFNWFAlf4sx8_jLxzGlx5IPHonjO6DnL68IM6ZwJVbFHxQmrJV8oWvGjw16Wx8VpSltKK1Ep-aQ4Fg2tpVL8pPh2iZBc63o3TAR8R8CYMYKZSLBkF3ICyacVcX7AeAt9Dnk3hOj8mqQhwoBrhymnSYsd3IzZ4_Hn9x_oN-ANdmQfw34z9WAGZ0iP-TVNZIgIww798LR4bKFP-Oz-eVZ8uXy3Wn5YXH98f7V8e70wZU3ZggkpsKzKlpdCdaWFRtbQdpwzidSyRrbALVVtU7a2EkaJuuxq2UhUtmwF4-KsuJq9XYCt3ke3gzjpAE7fBUJca4i5wh61aWwLoCB_I-u4BSNpy5S1llHF6yq73syu_djusDP5NyL0D6QPM95t9Drcasa4qppaZMOre0MMNyOmQe9cMtj34DGMSQuqqtzASqmMvvwH3YYx-nxXmWrqplGVKjP14u-SDrX8aXMGXs-AyfefItoDwqj-PUI6j5C-G6HMXszs19z76f-gXq4-zyd-AYtVywg
Cites_doi 10.1136/bmj.39500.885752.BE
10.1155/2022/8652062
10.1111/anec.12872
10.1007/s12471-022-01716-5
10.1016/j.hrthm.2022.04.016
10.1136/postgradmedj-2020-138661
10.1161/CIRCULATIONAHA.109.192704
10.1016/S2214-109X(20)30396-X
10.2174/1573403X10666140514103612
10.1093/ehjdh/ztab083
ContentType Journal Article
Copyright 2024 The Author(s). published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
2024 The Author(s). Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
– notice: 2024 The Author(s). Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
– notice: 2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7T5
7TK
7TM
7U9
7X7
7XB
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M7N
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
DOA
DOI 10.1111/cts.13861
DatabaseName Wiley Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



MEDLINE
Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate QT interval monitoring in leprosy treatment
EISSN 1752-8062
EndPage n/a
ExternalDocumentID oai_doaj_org_article_c9fbaa8aa9594b2fac50b18fff108276
PMC11286973
39075882
10_1111_cts_13861
CTS13861
Genre researchArticle
Randomized Controlled Trial
Clinical Trial, Phase II
Journal Article
GeographicLocations Comoro Islands
GeographicLocations_xml – name: Comoro Islands
GroupedDBID ---
05W
0R~
10A
1OC
24P
29B
31~
4.4
52S
53G
5GY
5VS
7X7
8-1
8FE
8FH
8FI
8FJ
AAHHS
AANHP
AAZKR
ABDBF
ABUWG
ACBWZ
ACCFJ
ACCMX
ACRPL
ACUHS
ACXQS
ACYXJ
ADKYN
ADNMO
ADZMN
ADZOD
AEEZP
AEQDE
AFBPY
AFKRA
AFZJQ
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AVUZU
BBNVY
BDRZF
BENPR
BHPHI
BPHCQ
BRXPI
BVXVI
CAG
CCPQU
COF
CS3
DIK
EBD
EBS
EJD
EMOBN
ESX
F5P
FEDTE
FYUFA
G-S
GODZA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IAO
IHR
ITC
KQ8
LH4
LK8
LW6
M7P
MY~
O9-
OIG
OK1
P2P
PIMPY
PQQKQ
PROAC
QB0
ROL
RPM
SUPJJ
SV3
TUS
UKHRP
WIN
XG1
AAYXX
AFFHD
AGQPQ
CITATION
PHGZM
PHGZT
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7T5
7TK
7TM
7U9
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
RC3
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c4701-1353e464b2438d4fa957abd2215e0f195ba2f08b94bf63c8374d7595e8f4b3123
IEDL.DBID DOA
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001280208900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1752-8054
1752-8062
IngestDate Mon Nov 10 04:31:06 EST 2025
Tue Nov 04 02:06:10 EST 2025
Fri Sep 05 11:24:09 EDT 2025
Sat Nov 29 14:25:50 EST 2025
Thu Apr 03 06:54:36 EDT 2025
Sat Nov 29 02:23:18 EST 2025
Wed Jan 22 17:14:45 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License Attribution-NonCommercial
2024 The Author(s). Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4701-1353e464b2438d4fa957abd2215e0f195ba2f08b94bf63c8374d7595e8f4b3123
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0009-0000-4448-0526
0000-0001-8703-8527
0000-0003-3291-8257
0000-0002-3881-9105
0000-0002-1017-4675
OpenAccessLink https://doaj.org/article/c9fbaa8aa9594b2fac50b18fff108276
PMID 39075882
PQID 3097998684
PQPubID 2029979
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_c9fbaa8aa9594b2fac50b18fff108276
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11286973
proquest_miscellaneous_3086062688
proquest_journals_3097998684
pubmed_primary_39075882
crossref_primary_10_1111_cts_13861
wiley_primary_10_1111_cts_13861_CTS13861
PublicationCentury 2000
PublicationDate August 2024
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: August 2024
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Clinical and translational science
PublicationTitleAlternate Clin Transl Sci
PublicationYear 2024
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2021; 9
2023; 31
2010; 121
2018
2021; 26
2008; 336
2021; 97
2022; 2022
2021; 2
2014; 10
2022; 19
e_1_2_11_7_1
e_1_2_11_6_1
e_1_2_11_4_1
e_1_2_11_3_1
e_1_2_11_2_1
World Health Organization. Regional Office for South‐East Asia (e_1_2_11_5_1) 2018
e_1_2_11_10_1
e_1_2_11_9_1
e_1_2_11_12_1
e_1_2_11_8_1
e_1_2_11_11_1
References_xml – volume: 26
  issue: 6
  year: 2021
  article-title: Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECG
  publication-title: Ann Noninvasive Electrocardiol
– volume: 336
  start-page: 761
  issue: 7647
  year: 2008
  end-page: 764
  article-title: Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial
  publication-title: BMJ
– volume: 19
  start-page: 1297
  issue: 8
  year: 2022
  end-page: 1303
  article-title: Risk of sudden cardiac death associated with QRS, QTc, and JTc intervals in the general population
  publication-title: Heart Rhythm
– volume: 10
  start-page: 287
  issue: 3
  year: 2014
  end-page: 294
  article-title: The measurement of the QT interval
  publication-title: Curr Cardiol Rev
– volume: 121
  start-page: 1047
  issue: 8
  year: 2010
  end-page: 1060
  article-title: Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation
  publication-title: Circulation
– volume: 2
  start-page: 643
  issue: 4
  year: 2021
  end-page: 648
  article-title: Clinical validation and evaluation of a novel six‐lead handheld electrocardiogram recorder compared to the 12‐lead electrocardiogram in unselected cardiology patients (EVALECG cardio)
  publication-title: Eur Heart J Digit Health
– year: 2018
– volume: 31
  start-page: 340
  issue: 9
  year: 2023
  end-page: 347
  article-title: Accuracy of mobile 6‐lead electrocardiogram device for assessment of QT interval: a prospective validation study
  publication-title: Neth Hear J
– volume: 97
  start-page: 452
  issue: 1149
  year: 2021
  end-page: 458
  article-title: Managing drug‐induced QT prolongation in clinical practice
  publication-title: Postgrad Med J
– volume: 9
  start-page: e81
  issue: 1
  year: 2021
  end-page: e90
  article-title: Leprosy post‐exposure prophylaxis with single‐dose rifampicin (LPEP): an international feasibility programme
  publication-title: Lancet Glob Health
– volume: 2022
  year: 2022
  article-title: Leprosy: a review of epidemiology, clinical diagnosis, and management
  publication-title: J Trop Med
– ident: e_1_2_11_4_1
  doi: 10.1136/bmj.39500.885752.BE
– ident: e_1_2_11_2_1
  doi: 10.1155/2022/8652062
– ident: e_1_2_11_11_1
  doi: 10.1111/anec.12872
– ident: e_1_2_11_7_1
  doi: 10.1007/s12471-022-01716-5
– volume-title: Guidelines for the Diagnosis, Treatment and Prevention of Leprosy
  year: 2018
  ident: e_1_2_11_5_1
– ident: e_1_2_11_10_1
  doi: 10.1016/j.hrthm.2022.04.016
– ident: e_1_2_11_8_1
  doi: 10.1136/postgradmedj-2020-138661
– ident: e_1_2_11_9_1
  doi: 10.1161/CIRCULATIONAHA.109.192704
– ident: e_1_2_11_3_1
  doi: 10.1016/S2214-109X(20)30396-X
– ident: e_1_2_11_6_1
  doi: 10.2174/1573403X10666140514103612
– ident: e_1_2_11_12_1
  doi: 10.1093/ehjdh/ztab083
SSID ssj0063685
Score 2.3282866
Snippet Some anti‐mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life‐threatening ventricular arrhythmia. However, the highest...
Some anti-mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life-threatening ventricular arrhythmia. However, the highest...
Abstract Some anti‐mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life‐threatening ventricular arrhythmia. However,...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e13861
SubjectTerms Accuracy
Adult
Arrhythmia
Automation
Diarylquinolines - administration & dosage
Diarylquinolines - adverse effects
Disease prevention
Drug dosages
Drug Therapy, Combination - methods
EKG
Electrocardiography
Ethics
Feasibility Studies
Female
Heart rate
Humans
Leprostatic Agents - administration & dosage
Leprostatic Agents - adverse effects
Leprosy
Leprosy - diagnosis
Leprosy - drug therapy
Long QT Syndrome - chemically induced
Long QT Syndrome - diagnosis
Male
Middle Aged
Performance evaluation
Prophylaxis
Rifampin
Rifampin - administration & dosage
Rifampin - adverse effects
Young Adult
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BQYgLb2igIIM4cAk4sZPYJwQVFReqIhapt8jPdqU2aTe7lfaAxE_gN_JLGHudhRWPC7ckdqKx5uHP9pcZgOfWVs6awufKozfx0lc59qS51VQ7yh1lmsZiE83-vjg8lAdpw21ItMoxJsZAbXsT9shfMRoOoEQt-Ouz8zxUjQqnq6mExmW4ErIksEjdOxgjcR2Sq8cfIiv0esQmKbNQYPKY-fCyYKIuNuajmLb_T1jzd8rkr1A2zkV7N_93FLfgRkKh5M3KbG7DJdfdgWsf0jn7XfiCyDDxZpdEdZYoYxYzZZak9-S0xwZHPk7INBIm8UOnMTKELUIyzMfkE9hMtLPqfDENWPb712-uO46EA4JSo3pP4g9a5MTh7bAka877Pfi8926y-z5PhRpywxta5KF2huM11yVnwnKvZNUobUtUiaO-kJVWpadCS659zQyuibltKlk54blmOHfeh62u79w2EO6ZK7mutaCWG0oVvsEL4RpZWsmtyeDZqK72bJWPox3XMajTNuo0g7dBkesOIYV2fNDPjtrkka2RXislFAqLcpVemYrqQnjvC4RFTZ3BzqjCNvn10P7UXwZP183okeGYRXWuX4Q-AleFZS1EBg9WVrOWhEmEaLioyUBs2NOGqJst3fQ4Zv1GYCxq2bAMXkTT-_vw293Jp3jx8N9DeATXS4RoKzrjDmzNZwv3GK6ai_l0mD2JrvQD-J0sWQ
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Open Access
  dbid: 24P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5VBSEulHdTCjKIA5cgx3ESW5zaiooLVRGL1FvkJ12pTehmF2kPSPwEfiO_hLHzUFeAhMQtie1obM9nf2OPxwAvrS2cNZlPlUc0ceaLFHPS1GqqHeWO5prGyyaqkxNxdiZPt-DNeBamjw8xLbgFZMTxOgBc6e4ayM2ye53lIpg-NzJ8CPc2MH46DsNliKweT0MWCHkkJkNYoeDGMxXdmIxizP4_Ec3f_SWv89g4ER3v_FcV7sKdgX-Sg15h7sGWa-7DrffDDvsD-IaccPCYXRPVWKKMWS2UWZPWk8sWExz5MCPz6CqJP7qMY0JYHCTdcgw7gclEO6uuVvMg5M_vP1xzHl0NCFYbO_YiHs0iFw5fuzWZvN0fwqfjt7Ojd-lwRUNqeEWzNNya4XjJNeO5sNwrWVRKW4ZEwlGfyUIr5qnQkmtf5gatYW6rQhZOeK5znDUfwXbTNm4XCPe5Y1yXWlDLDaUKS_BMuEoyK7k1CbwY-6r-0kfiqEcLBhuyjg2ZwGHoxSlDCJ4dP7SLz_WAxdpIr5USCoVFuZhXpqA6E977DAlRVSawP-pAPSC6q3MaNkBFKXgCz6dkxGLYYFGNa1chj0B7kJVCJPC4V5lJklwiOUNzJgGxoUwbom6mNPPzGO8bKbEoZZUn8Cpq09-rXx_NPsaHvX_P-gRuMyRqvVPjPmwvFyv3FG6ar8t5t3gWMfULNsspbw
  priority: 102
  providerName: Wiley-Blackwell
Title Feasibility and accuracy of mobile QT interval monitoring strategies in bedaquiline‐enhanced prophylactic leprosy treatment
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcts.13861
https://www.ncbi.nlm.nih.gov/pubmed/39075882
https://www.proquest.com/docview/3097998684
https://www.proquest.com/docview/3086062688
https://pubmed.ncbi.nlm.nih.gov/PMC11286973
https://doaj.org/article/c9fbaa8aa9594b2fac50b18fff108276
Volume 17
WOSCitedRecordID wos001280208900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1752-8062
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0063685
  issn: 1752-8054
  databaseCode: DOA
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1752-8062
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0063685
  issn: 1752-8054
  databaseCode: M7P
  dateStart: 20160201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest - Health & Medical Complete保健、医学与药学数据库
  customDbUrl:
  eissn: 1752-8062
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0063685
  issn: 1752-8054
  databaseCode: 7X7
  dateStart: 20160201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1752-8062
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0063685
  issn: 1752-8054
  databaseCode: BENPR
  dateStart: 20160201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1752-8062
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0063685
  issn: 1752-8054
  databaseCode: PIMPY
  dateStart: 20160201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 1752-8062
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0063685
  issn: 1752-8054
  databaseCode: WIN
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 1752-8062
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0063685
  issn: 1752-8054
  databaseCode: 24P
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BixAXxJtAWRnEgUvASZzEPtKqFT10FWARyynyU12pzdLNbqU9IPET-I38EsZOsuoKEBcuUZJxImce8TfxlzHAS2Nya3TiYukwmljq8hhb0tgoqixllmaKhsUmyvGYT6eiurLUl-eEdeWBO8W90cIpKbmUIhdMpU7qnKqEO-cSHL3KUGwbUc-QTHXv4MKXVQ-_QuYY74hK-ppCnsOjl-3rJONFsjUShYL9f0KZv5Mlr4LYMAod3YHbPXwkb7tu34VrtrkHN0_6CfL78A0hXU94XRPZGCK1Xi2kXpO5I-dzFFjyfkJmgemINzoPIe2_7ZF2OVSNQDFR1siL1cyD0J_ff9jmNDAFCHYc7XIW_qwiZxYP2zXZkNUfwKejw8nBu7hfYSHWrKRJ7Be9sKxAvbKMG-ZQyaVUJkUcYKlLRK5k6ihXqHlXZBqTWWbKXOSWO6YyHPQewk4zb-xjIMxlNmWqUJwapimVeAVLuC1FagQzOoIXg7brr10hjXpIQNAkdTBJBPveDpsGvvZ1OIEeUfceUf_LIyLYG6xY9wHZ1hn185e84CyC5xsxhpKfH5GNna98G47pXFpwHsGjzuibnmQCsRVmIxHwLXfY6uq2pJmdhnLdiGh5IcosglfBc_7--PXB5GPYefI_9PAUbqWIwDq24h7sLBcr-wxu6MvlrF2M4HrKKtyW0zJs-Qh29w_H1YdRiKSRJ8GifLc6Pqm-4NHn4_Evd_gnMQ
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL2qCgI2vB-BAgaBxCbgOE7iLBCCQtWqDxUxSN2lftKR2qSdzIBmgcQn8CV8FF_CtScZGPHYdcEuiZ3ITo6vz42P7wV4ZExmjU5cLB2OJs5cFmNNGhtFlaXc0lTRkGyi2NkRe3vl7hJ86_fCeFllbxODoTaN9v_In6XUL0CJXPAXxyexzxrlV1f7FBozWGza6Sd02drnG6_x-z5mbO3NYHU97rIKxJoX6Dv7RA-W51wxngrDnSyzQirDcO6z1CVlpiRzVKiSK5enGh04boqszKxwXKWJD3SAJv8M0ggmglRwt7f8uQ_mHjZgZmhlkAt1kYy8ckiP26dJKvJkYf4LaQL-xG1_l2j-Sp3D3Ld26X97a5fhYseyycvZsLgCS7a-Cue2Ox3BNfiMzLfTBU-JrA2RWk9GUk9J48hRgwWWvB2QYRCE4oOOguXzv0BJO-6Da2AxUdbIk8nQc_XvX77a-iAIKgi-JYTvYdiARg4tnrZTMtf0X4f3p9L5G7BcN7W9BYS71DKuciWo4ZpSiXfwRNiiZKbkRkfwsIdHdTyLN1L1fhpiqAoYiuCVB868gg8RHi40ow9VZ3EqXTolpZDYWGwXc1JnVCXCOZcg7SvyCFZ6yFSd3Wqrn3iJ4MG8GC2OX0aStW0mvo5Ar5flQkRwc4bSeUvSEikoOm0RiAX8LjR1saQeHoSo5kj8RV4WaQRPAtT_3v1qdfAuHNz-dxfuw_n1wfZWtbWxs3kHLjCkozPp5gosj0cTexfO6o_jYTu6F4Yxgf3THgE_AANlhow
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL2qCqrY8H4EChgEEptQJ3ESZ4EQtIyoCqNBDFJ3wU86Upu0kxnQLJD4BL6Hz-FLuHaSgRGPXRfsktiJ7OT4-tz4-F6AB1qnRqvIhsLiaGKxTUOsSUMtqTSUGZpI6pNN5MMh398vRmvwrd8L42SVvU30hlrXyv0j30qoW4DiGWdbtpNFjHYGT49PQpdByq209uk0WojsmcUndN-aJ7s7-K0fxvHgxXj7ZdhlGAgVy9GPdkkfDMuYjFnCNbOiSHMhdYzzoKE2KlIpYku5LJi0WaLQmWM6T4vUcMtkErmgB2j-z-QuaLmXDY76WSBzgd39ZswULQ7yoi6qkVMRqVnzOEp4Fq3MhT5lwJ947u9yzV9ptJ8HBxf-5zd4Ec537Js8a4fLJVgz1WXYeN3pC67AZ2TEnV54QUSliVBqPhVqQWpLjmosMOTNmEy8UBQfdOQtovs1SppZH3QDi4k0WpzMJ47Df__y1VQHXmhB8I0hrA_9xjRyaPC0WZCl1v8qvDuVzl-D9aquzA0gzCYmZjKTnGqmKBV4B4u4yYtYF0yrAO73UCmP2zgkZe-_IZ5Kj6cAnjsQLSu40OH-Qj39UHaWqFSFlUJwgY3FdsVWqJTKiFtrI6SDeRbAZg-fsrNnTfkTOwHcWxajJXLLS6Iy9dzV4egNxxnnAVxvEbtsSVIgNUVnLgC-guWVpq6WVJMDH-0cHQKeFXkSwCMP-793v9wev_UHN__dhbuwgcAvX-0O927BuRhZaqvo3IT12XRubsNZ9XE2aaZ3_Igm8P60B8APDy2PSQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Feasibility+and+accuracy+of+mobile+QT+interval+monitoring+strategies+in+bedaquiline%E2%80%90enhanced+prophylactic+leprosy+treatment&rft.jtitle=Clinical+and+translational+science&rft.au=Bergeman%2C+Auke+T.&rft.au=Nourdine%2C+Said&rft.au=Piubello%2C+Alberto&rft.au=Salim%2C+Zahara&rft.date=2024-08-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=1752-8054&rft.eissn=1752-8062&rft.volume=17&rft.issue=8&rft_id=info:doi/10.1111%2Fcts.13861&rft.externalDocID=PMC11286973
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1752-8054&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1752-8054&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1752-8054&client=summon